Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/11/1989 | EP0336760A2 Bone-inducing protein |
10/11/1989 | EP0336736A1 Purification of pertussis toxins and production of vaccine |
10/11/1989 | EP0336562A1 Improvements relating to antigens |
10/11/1989 | EP0336523A1 Method for the in-vivo production and testing of proteins by recombinant gene expression in selected host-cells |
10/11/1989 | EP0336441A2 Anti-CPBII monoclonal antibody |
10/11/1989 | EP0336412A2 Synthetic oligonucleotides useful for the determination of Chlamydia trachomatis in a biological sample |
10/11/1989 | EP0336405A2 Anti-human cancer protein complexes, their production and use |
10/11/1989 | EP0336383A2 Novel recombinant human lymphotoxin |
10/11/1989 | EP0336379A2 Antibody heteroconjugates for use in regulation of lymphocyte activity |
10/11/1989 | EP0336368A2 N2-(1-carboxy-3-phenylpropyl)-L-lysine derivative and process of producing lysinopril using the compound |
10/11/1989 | EP0336341A2 Baculovirus proteins and viral pesticides containing same |
10/11/1989 | EP0336324A1 Process for treating insoluble fused heterogenic protein |
10/11/1989 | EP0336230A2 Cyclic peptide antagonists of Substance P and Substance K |
10/11/1989 | EP0336155A1 Recombinant human cardiac myosin |
10/11/1989 | EP0335949A1 Paired helical filament core and antibody thereto useful in diagnosing alzheimer's disease |
10/11/1989 | EP0335900A1 Human interleukin-4 muteins |
10/11/1989 | CN1036135A Growth inhibiting agent and use thereof |
10/10/1989 | US4873317 Method of separating or purifying proteins and other biopolymers |
10/10/1989 | US4873316 Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
10/10/1989 | US4873312 Unfolding in denaturing solution; diafiltration |
10/10/1989 | US4873222 Placenta-derived anticoagulating substance |
10/10/1989 | US4873221 Difluoro peptide compounds |
10/10/1989 | US4873190 Heterodimeric T lymphocyte receptor |
10/10/1989 | US4873188 Method, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodies |
10/05/1989 | WO1989009403A1 Diagnostic methods and systems for quantifying apo ai |
10/05/1989 | WO1989009393A1 Luminescent chimeric proteins |
10/05/1989 | WO1989009286A1 PROTAMINE-REACTIVE IgM ANTIBODIES |
10/05/1989 | WO1989009277A1 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
10/05/1989 | WO1989009273A1 Methods and compositions incorporating autoimmune antigenic epitopes |
10/05/1989 | WO1989009271A1 Recombinant retroviruses |
10/05/1989 | WO1989009269A1 The gene encoding phosphoribosylaminoimidazolecarboxylase of schwanniomyces occidentalis |
10/05/1989 | WO1989009268A1 Production of insulin-like growth factor binding protein |
10/05/1989 | WO1989009267A2 Dna promoter fragments from wheat |
10/05/1989 | WO1989009264A1 DNA SEQUENCES CONTAINING THE FUNCTIONAL PART OF THE LOCUS sacU AND OF THE LOCUS sacUh OF B. SUBTILIS, VECTORS CONTAINING SAID SEQUENCES AND THEIR USE IN PROTEIN PRODUCING PROCESSES |
10/05/1989 | WO1989009261A1 Diagnosis of mycobacterium bovis infection |
10/05/1989 | WO1989009260A1 Ryegrass pollen allergen |
10/05/1989 | WO1989009232A1 Neuropeptide antagonists |
10/05/1989 | WO1989009231A1 Therapeutic peptides |
10/05/1989 | WO1989009230A1 Therapeutic peptides |
10/05/1989 | WO1989009228A1 Peptides |
10/05/1989 | WO1989009227A2 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis |
10/05/1989 | WO1989009226A1 Peptides |
10/05/1989 | WO1989009225A1 Nerve growth factor peptides |
10/05/1989 | WO1989009223A1 Dna binding proteins including androgen receptor |
10/05/1989 | WO1989009220A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
10/05/1989 | WO1989009065A1 Large-scale production of bovine leukocyte interferon |
10/05/1989 | WO1989009064A1 Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
10/05/1989 | WO1989009063A1 Novel non-reverting shigella live vaccines |
10/04/1989 | EP0335854A2 Regulated gene expression in gram-negative microorganisms |
10/04/1989 | EP0335662A1 Peptides |
10/04/1989 | EP0335654A2 Odorant-binding protein from rat |
10/04/1989 | EP0335637A2 Nerve growth factor peptides |
10/04/1989 | EP0335635A1 Mutated HIV envelope protein |
10/04/1989 | EP0335567A2 Controlled release of periplasmic proteins into the medium |
10/04/1989 | EP0335554A2 Cosmetic composition |
10/04/1989 | EP0335550A1 Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof |
10/04/1989 | EP0335476A2 Recombinant methods for the production of ricin a, ricin b, ricin or diphtheria toxin (dt)a or ab' fragment, suitable hosts and vectors therefor, and conjugates comprising ricin toxin a chain or diphtheria toxin |
10/04/1989 | EP0335426A2 Compositions and process for protecting T lymphocytes against the etiological agent of lymphadenopathy and acquired immunodepression syndrom |
10/04/1989 | EP0335423A2 Modified human G-CSF |
10/04/1989 | EP0335400A2 Processes for production of human epidermal growth factor by genetic engineering |
10/04/1989 | EP0335263A2 Anti-human lymphotoxin monoclonal antibody, hybridoma for production thereof, anti-human lymphotoxin-C-terminal peptide antibody and method for detecting human lymphotoxin thereby |
10/04/1989 | EP0335243A2 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
10/04/1989 | EP0335135A2 Production of monoclonal antibodies specific for non-A, non-B hepatitis infected liver |
10/03/1989 | US4871835 Analogs of hGH having antagonistic activity, and uses thereof |
10/03/1989 | US4871834 Anticarcinogenic agents, genetic engineering |
10/03/1989 | US4871717 Peptides |
10/03/1989 | US4871670 Dna transfer vector |
10/03/1989 | US4871663 Exporession vector for human TnF |
10/03/1989 | US4871659 Reagent for detecting non-A, non-B viral hepatitis (NANBH) and an immunoenzymatic method for detecting NANBH antigens in fecal extracts |
09/28/1989 | DE3808456A1 Polypeptides for use in spasmolytic pharmaceuticals or as neurotransmitters |
09/27/1989 | EP0334685A2 Bradykinin analogues, their synthesis and their use in therapy |
09/27/1989 | EP0334632A2 Novel antibiotic |
09/27/1989 | EP0334530A1 A recombinant marek's disease virus and a vaccine |
09/27/1989 | EP0334301A1 Recombinant retroviruses |
09/27/1989 | EP0334278A2 Process of purification of a 168kD protein from Mycoplasma pneumoniae |
09/27/1989 | EP0334165A2 Monoclonal antibodies |
09/26/1989 | USRE33071 Complexing |
09/26/1989 | US4870163 Purification by multistage adsorption |
09/26/1989 | US4870161 Reagents and probes for distinguishing and isolating different GTP-binding proteins |
09/26/1989 | US4870160 Polypeptides with laminin activity |
09/26/1989 | US4870159 Leucine-specific regulatory locus |
09/26/1989 | US4870055 Segmented polypeptide bioelastomers to modulate elastic modulus |
09/26/1989 | US4870054 Treatment for osteoporosis using GRF or a biologically active analog thereof |
09/26/1989 | US4870053 Antiallergy acyl glycoprotein from klebsiella |
09/26/1989 | US4870023 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
09/26/1989 | US4870017 Bacterial methionine N-terminal peptidase |
09/26/1989 | US4870016 Changing solubility of enzymes |
09/26/1989 | US4870015 Dna sequences, genetic engineering |
09/26/1989 | US4870013 SV40 early and RSV promoters useful in saccharomyces expression |
09/26/1989 | US4870009 Hormones |
09/26/1989 | US4870008 Secretory expression in eukaryotes |
09/26/1989 | US4870006 Medical diagnosis, immunoassay |
09/26/1989 | US4869903 Human innumedeficiency virus; single-chain ribosome inactivating protein |
09/26/1989 | EP0329693A4 Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same. |
09/26/1989 | CA1262016A1 Anticancer agent |
09/26/1989 | CA1262014A1 Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies |
09/26/1989 | CA1262010A1 Amino thiol peptides |
09/26/1989 | CA1261550A1 Chemically defined vaccine against urinary infections |
09/26/1989 | CA1261549A1 Polypeptide cartilage-inducing factors found in bone |
09/26/1989 | CA1261548A1 Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use |